<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
68594-029-99
</NDCCode>
<PackageDescription>
750 mg in 1 BOTTLE (68594-029-99)
</PackageDescription>
<NDC11Code>
68594-0029-99
</NDC11Code>
<ProductNDC>
68594-029
</ProductNDC>
<ProductTypeName>
BULK INGREDIENT
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Moxetumomab Pasudotox-tdfk
</NonProprietaryName>
<DosageFormName>
POWDER
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20180913
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
BULK INGREDIENT
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Boehringer Ingelheim RCV GmbH & Co KG
</LabelerName>
<SubstanceName>
MOXETUMOMAB PASUDOTOX-TDFK
</SubstanceName>
<StrengthNumber>
1
</StrengthNumber>
<StrengthUnit>
mg/mg
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2014-02-04
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
13-SEP-18
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>